Related Experiment Video
Updated: Aug 10, 2026

Assessment of Morphine-induced Hyperalgesia and Analgesic Tolerance in Mice Using Thermal and Mechanical Nociceptive Modalities
Published on: July 29, 2014
Oral administration of dextromethorphan prevents the development of morphine tolerance and dependence in rats
1Department of Anesthesiology, Medical College of Virginia, Virginia Commonwealth University, Richmond 23298, USA.
Abstract:
Combined oral administration of morphine sulfate (MS) and the over-the-counter antitussive drug and N-methyl-D-aspartate receptor antagonist dextromethorphan (DM) prevented the development of tolerance to the antinociceptive effects of MS (15, 24, or 32 mg/kg) in rats. This combined oral treatment regimen also attenuated signs of naloxone-precipitated physical dependence on morphine in the same rats. A wide range of ratios of MS to DM (2:1, 1:1, and 1:2) were effective for preventing the development of morphine tolerance and dependence. In addition, we provide evidence that under certain circumstances DM increases the acute antinociceptive effects of MS. All of these results indicate that oral treatment that combines DM with opiate analgesics may be a powerful approach for simultaneously preventing opiate tolerance and dependence and enhancing analgesia in humans.
Insights
Combining morphine sulfate (MS) with dextromethorphan (DM) orally prevented tolerance and dependence on MS in rats. This combination also enhanced MS pain relief, suggesting a novel approach for managing pain and opioid-related side effects.
Area of Science:
- Pharmacology
- Neuroscience
- Pain Management
Background:
- Opioid analgesics like morphine sulfate (MS) are effective for pain but can lead to tolerance and dependence.
- Dextromethorphan (DM), an NMDA receptor antagonist and antitussive, has shown potential in modulating opioid effects.
Purpose of the Study:
- To investigate the efficacy of combined oral administration of MS and DM in preventing the development of tolerance and physical dependence on MS.
- To assess whether DM can enhance the acute antinociceptive effects of MS.
Main Methods:
- Rats were administered varying oral doses of MS alone or in combination with DM.
- Tolerance to MS antinociception was assessed after repeated administration.
- Physical dependence was evaluated through naloxone-precipitated withdrawal signs.
- Acute antinociceptive effects of MS and DM combinations were measured.
Main Results:
- Combined oral MS and DM administration prevented the development of tolerance to MS's antinociceptive effects across different MS doses.
- This combination regimen also attenuated signs of naloxone-precipitated physical dependence on MS.
- Various ratios of MS to DM (2:1, 1:1, 1:2) were effective in preventing tolerance and dependence.
- DM was observed to enhance the acute antinociceptive effects of MS under certain conditions.
Conclusions:
- Oral co-administration of dextromethorphan with morphine sulfate is a promising strategy for preventing opioid tolerance and dependence.
- This combined approach may also enhance analgesia, offering a potential therapeutic advantage in pain management.
- Further research into combining DM with opioid analgesics could lead to improved patient outcomes by mitigating major side effects.
Related Concept Videos
Drug Abuse and Addiction: Pharmacological Phenomena
Opioid Receptors: Overview
Analgesia and Pain Management
Opioid Analgesics: Morphine and Other Natural Cogeners
Opioid Analgesics: Synthetic and Semisynthetic Opioids
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by anesthetizing...

